Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
Félix Ackermann(Hôpital Foch), Romain Paule(Délégation Paris 5), Marc Vasse(Hôpital Foch), Charles Cerf(Hôpital Foch), Jean‐Emmanuel Kahn(Université de Versailles Saint-Quentin-en-Yvelines), Hélène Salvator(Université Paris-Saclay), Alexandre Vallée(Hôpital Foch), Y. Schoindre(Hôpital Foch), Colas Tchérakian(Inserm), Mathilde Roumier(Hôpital Foch), Anne‐Laure Brun(Hôpital Foch), Anne-Gaëlle Si Larbi(Hôpital Foch), Matthieu Groh(Hôpital Saint-Louis), Anne Verrat(Hôpital Foch), Ibrahim Marroun(Hôpital Foch), Guillaume Géri(Hôpital Avicenne), Julien Rohmer(Hôpital Cochin), Benjamin Zuber(Hôpital Foch), D. Khau(Hospices Civils de Lyon), Thierry Chinet(Université Paris-Saclay), Matthieu Ponsoye(Université Paris-Saclay), Erwan Fourn(Inserm), Louis‐Jean Couderc, A. Roux(Sorbonne Université), Éric Farfour(European Foundation for Clinical Nanomedicine), Marie-Alice Colombier(Inserm), Marie-Laure Chabi(Université Paris-Saclay), Marie Ballester(Hôpital Foch)
Cited by 53
Related Papers
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study
|The Lancet Respiratory Medicine|2021|257
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
|Blood|2012|241
Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study
|EBioMedicine|2020|226